Sort
326,823 grants matching “clinical trial”
Vaccine Treatment Evaluation Units(VTEU) mRNA-1273-P204 Moderna Pediatric
$1,585,845Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2021 · AI
Tumor Hypoxia: Molecular Studies and Clinical Exploitation
$1,585,768Amato J. Giaccia · Stanford University · P01 · FY2016 · CA
Tumor Hypoxia: Molecular Studies and Clinical Exploitation
$1,585,768Amato J. Giaccia · Stanford University · P01 · FY2017 · CA
Tumor Hypoxia: Molecular Studies and Clinical Exploitation
$1,585,768Amato J. Giaccia · Stanford University · P01 · FY2015 · CA
Molecular Gene and Radiation Therapies for Cancer
$1,585,764Henry Ford Health System · P01 · FY2005 · CA
Novel mGlu5 negative allosteric modulators as first-in-class non-addictive analgesic therapeutics
$1,585,635Jerri Michelle Rook · Vanderbilt University · UG3 · FY2019 · NS
Interrupting the Vicious Cycle of Obesity and Metabolic Syndrome
$1,585,560Jacob E Friedman · University Of Colorado Denver · R24 · FY2016 · DK
A Patient Activation Intervention to Enhance Bone Health
$1,585,381Peter M Cram · University Of Iowa · R01 · FY2012 · AG
Chiropractic Care for Veterans: A Pragmatic Randomized Trial Addressing Dose Effects for cLBP
$1,585,301Cynthia R Long · Palmer College Of Chiropractic · UH3 · FY2021 · AT
Integrative Molecular Epidemiology of Human Cancer
$1,585,226Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Biomarkers in Cancer Diagnosis,Prognosis, and Therapeutic Outcome
$1,585,226Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
African Americans with Glaucoma: Structure and Function
$1,585,206University Of California San Diego · U10 · FY2003 · EY
Molecular Signatures of Lung Cancer
$1,585,181David P Carbone · Vanderbilt University · U01 · FY2007 · CA
Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease
$1,585,167Li-Huei Tsai · Massachusetts Institute Of Technology · U01 · FY2024 · AG
Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterms - DCC
$1,585,046Abhik Das · Research Triangle Institute · U01 · FY2019 · HL
Papillomavirus Virion Proteins and Vaccines
$1,585,014John T. Schiller · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Scaling up eConnect in Juvenile Probation Settings: a hybrid implementation-effectiveness trial of a digital suicide risk/behavior identification and linkage-to-treatment system
$1,584,966Katherine S Elkington · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2022 · MH
TCIA Sustainment and Scalability - Platforms for Quantitative Imaging Informatics in Precision Medicine
$1,584,883Fred William Prior · Univ Of Arkansas For Med Scis · U24 · FY2020 · CA
Host innate immune-microbial interactions and intestinal inflammation
$1,584,843Ryan Balfour Sartor · Univ Of North Carolina Chapel Hill · P01 · FY2017 · DK
Comparison of High vs. Standard Dose Flu Vaccine in Pediatric Stem Cell Transplant Recipients
$1,584,794Natasha Bassam Halasa · Vanderbilt University Medical Center · U01 · FY2018 · AI
University of Pennsylvania Prevention Research Center
$1,584,760Karen Glanz · University Of Pennsylvania · U48 · FY2016 · DP
Physical and Biological Determinants for Optimal PDT
$1,584,723Massachusetts General Hospital · P01 · FY2005 · CA
Impact of Smoking on Lung Cancer Chemoprevention
$1,584,709University Of Texas Md Anderson Can Ctr · P01 · FY2001 · CA
Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease
$1,584,706Li-Huei Tsai · Massachusetts Institute Of Technology · U01 · FY2023 · AG
Development of Pre-Erythrocytic Malaria Vaccines and antibodies
$1,584,649Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI